Striving for the Next Generation in Tonometry
Investigational device for measuring intraocular pressure, a key factor in glaucoma diagnosis and treatment
LightTouch will deliver GAT-based precision with point-of-care practicality— a clinically significant combination for the first time in tonometry. LightTouch devices are not yet cleared by the FDA.
Objectives in Progress:
PRECISION
More precise intraocular pressure (IOP) measurements will empower eye care professionals (ECPs) and patients to better safeguard vision. Our measurement technique is force-area, based on the industry gold-standard Goldmann Application Tonometer (GAT).
PRACTICALITY
Portable, cost-effective, and usable by an informal caregiver at home, LightTouch will extend GAT-based precision beyond the eye clinic.
DATA PROLIFERATION
A global, device-comparable IOP dataset does not yet exist. LightTouch's combination of precision and practicality will enable the creation of this dataset. LightTouch IOP and associated data will be uniquely valuable to ECPs, patients, and researchers (academic, pharma, public health). LightTouch will create data markets that are currently unfulfilled.
Discovering
The Problem
Economic Burden
in 2017
Glaucoma is the most common cause of irreversible visual loss.
US Glaucoma Population
(all types)
US and global includes the estimated 50% that are undiagnosed.
Global Glaucoma Population
(all types)
Defending Against Glaucoma
For Every Memory Yet To Be Seen
The incidence of glaucoma increases with age. Globally and in the US, the 55+ age group is growing proportionally faster.
LightTouch devices are not yet cleared by the FDA. Our goal is to make our devices widely available and open new markets.
How It Works
Our 3.06mm acrylic tip is without seams or glue. This construction aligns with CDC guidelines for inhibition of pathogen transmission.